Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2018-10-24 2018-10-24
Drug Identification Number 02296284 02296284
Brand name ELOXATIN ELOXATIN
Common or Proper name Eloxatin Solution 200mg/40ml Eloxatin Solution 200mg/40ml
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients OXALIPLATIN OXALIPLATIN
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 1
ATC code L01XA L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-10-19 2018-10-19
Actual discontinuation date 2018-10-19 2018-10-19
Remaining supply date 2018-10-19 2018-10-19
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments